KT-1

• Description :

  KT-1 is a vasodilator. KT 1 can decrease aortic pressure, renal blood flow, left ventricular enddiastolic pressure and resistances of total peripheral, vertebral, coronary and renal vasculatures and increase aortic blood flow, vertebral blood flow, coronary blood flow, peak positive left ventricular dP/dt and heart rate in anesthetized open-chest dogs. KT-1 can be used for the research of cardiovascular disease[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H301-H315-H319-H335

• Target :

  Others

• Related Pathways :

  Others

• Field of Research :

  Cardiovascular Disease

• Smiles :

  COC1=C(C(OC)=CC2=C(N=CN=C12)NCCCCCO[N+]([O-])=O)OC

• Molecular Formula :

  C16H22N4O6

• Molecular Weight :

  366.37

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations :

  [1]Miyamoto Y, et al. Pharmacological properties of 5-[ (6,7,8-trimethoxy-4-quinazolinyl) amino]-1-pentanyl nitrate maleate in cardiovascular system. Arzneimittelforschung. 1991 Dec;41 (12) :1216-21.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [47487-05-8]